Huijun Xu

机构：Shandong University of Technology · ORCID：0000-0002-3253-0706

发表论文 291 篇 · 总被引 5066 次 · h-index 36

代表论文

• Novel Hypochlorous Acid-Activated Near-Infrared Probe Monitors the Dynamic Changes of Myeloperoxidase Activity in Ischemic Brain (2025 · Journal of Medicinal Chemistry · 被引 20)
• Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma (2025 · Journal for ImmunoTherapy of Cancer · 被引 17)
• Safety and Efficacy of Rechallenge With Immune Checkpoint Inhibitors in Advanced Solid Tumor: A Systematic Review and Meta‐Analysis (2024 · Cancer Medicine · 被引 15)
• Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia (2025 · Experimental Hematology and Oncology · 被引 9)
• Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus (2024 · Journal of Virology · 被引 8)
• Stereoselective and concentration-dependent induction of triazole resistance in Cryptococcus neoformans by agricultural fungicide tebuconazole (2025 · Journal of Hazardous Materials · 被引 6)